
While pharma is not synchronized with the boom and bust of the general economy, lessons from the business cycle facing manufacturers can enable the pharmaceutical industry to tackle the problems it faces.
Chris Hart, UK Partner of global business performance consultancy McKinney Rogers.

Published: September 25th 2009 | Updated: